Pediatric Solid Tumor

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

B7-H3.CD28Z.CART in Solid Tumors

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

GVAX Plus Checkpoint Blockade in Neuroblastoma

UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors

Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)

Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy

A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric Magnetic Resonance Imaging.

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients